Updates from the International Centre for Antimicrobial Resistance Solutions | International centre for antimicrobial resistance solutions

Updates from the International Centre for Antimicrobial Resistance Solutions

Published

Dear partners and colleagues,  

We are excited to share our latest newsletter and ICARS’ recent activities and efforts to address antimicrobial resistance (AMR) in Low- and Middle-Income Countries (LMICs) in the last several months.   

As we enter the last stretch leading up to the UN General Assembly High-level Meeting (UNGA HLM) on AMR, the technical and political work to formulate recommendations to feed into the political declaration is in full force. In mid-May, ICARS’ leadership and partnerships team engaged with key stakeholders in Geneva during the World Health Assembly (WHA) at various events, such as co-hosting a meeting at the residence of the Danish delegation to the UN and the Lancet series launch event and participating at the launch of the AMR Global Legislators Report. Drawing from ICARS’ experience over the years, we have produced a document with our recommendations for the UNGA HLM political declaration this September.

Alongside the activities during the WHA, ICARS participated in the celebrations of the 100th World Organisation for Animal Health General Session in Paris and underscored the importance of supporting and financing country-specific AMR actions during the FAO council's 175th session.  

As some of the first projects initiated by ICARS are nearing completion, we are pleased to see that the human health project in Georgia has taken significant strides as outcomes from the project informed stewardship guidelines that were included in the country’s new National Action Plans earlier this June. 

In the last quarter, ICARS has also established new partnerships in Vietnam, joining forces on critical research projects investigating the use of vaccination in fish and Kenya, on the access and development of novel antibiotics. During a trip to Vietnam, ICARS joined the Danish Minister of Agriculture delegation to visit the ICARS project sites and conduct high-level discussions with our Vietnamese partners. Moreover, ICARS attended the RENOFARM project launch in China to address AMR in the agrifood sector and presented ICARS’ work and projects in the animal health sector. 

Another major development at ICARS is our initiative to expand of our project portfolio, focusing on the environment and its role in the spread of resistant pathogens. To produce the necessary evidence on the intersection between the environment and AMR, ICARS is calling for project proposal submissions by August 1st.  

We are also thrilled to share with you our Year in Review for 2023, where we dive deep into the different activities and achievements at ICARS during the past year. 

In the upcoming summer period, ICARS will engage in a variety of exciting activities and conferences, so make sure you stay updated and read our newsletter in the fall! 

 

Warm regards,  

ICARS  

ICARS’ Recommendations to the UN General Assembly’s High-level Meeting on AMR

In September 2024, recognising the critical importance of antimicrobial resistance (AMR) and its impact, the UN General Assembly (UNGA) is convening a High-Level Meeting (HLM) to discuss and agree on a political declaration to inform future actions on AMR. Throughout 2024, ICARS has and will continue engaging in national, regional and global dialogue to feed into the HLM Political Declaration drawing on its experience over the past five years partnering with 21 Low- and Middle-Income Countries (LMICs) in their efforts to address AMR.

Read the recommendations here

Request for Proposals for Addressing the Environmental Dimensions of AMR through intervention and implementation

Antimicrobial resistance (AMR) is extensively described in humans, animals, and to a lesser extent in the environment as the key One Health sectors. However, the relative roles of these sectors in the development, transmission, and persistence of AMR, and the associated risks to human and animal health, are yet to be unequivocally elaborated. This is a call for multi-disciplinary intervention and implementation research proposals that mitigate the impact of antimicrobials and AMR in the natural and/or built environment on human and animal health.

Apply here

Financing Antimicrobial Resistance Interventions: Optimising Current and New Funding Mechanisms for Mitigation

During the 77th World Health Assembly in May 2024 in Geneva, the Ministry for the Interior and Health of Denmark, AMR Action Fund, Novo Nordisk Foundation, and ICARS convened governments and key stakeholders for a high-level side event to address one of the most pressing global health challenges today: antimicrobial resistance (AMR). Leading up to the high-level meeting on AMR during the UN General Assembly in September, this roundtable discussion focused on ensuring that tangible global actions will be taken and called for the optimisation of current and new financing mechanisms for AMR mitigation.

Download the summary brief of the discussion

ICARS human health project marks a step forward in the mitigation of AMR in Georgia

The ICARS project, spanning across ten hospitals, concentrates on key surgical procedures including herniorrhaphy, hip joint surgery, endoprosthesis, and Caesarean section. Through four comprehensive Work Packages (WPs), the project aims to promote prudent antibiotic use for Surgical Antibiotic Prophylaxis (SAP) by instituting an antimicrobial stewardship program (ASP). Notable developments include integration into Georgia’s National Action Plan and capacity-building achievements, marking significant milestones in the country’s ongoing efforts to address AMR.

Read more

ICARS Science Advisor Travels to China for RENOFARM Launch and Collaboration

In April, Dr. Kristina Osbjer, Senior Science Advisor in veterinary sciences at ICARS, travelled to China to participate in the RENOFARM (Reduce the Need for Antimicrobials on Farms for Sustainable Agrifood Systems Transformation) launch and engage with key stakeholders, aiming to foster future collaborations to address antimicrobial resistance in the agrifood sector.

Read more

Mitigating the Effects of Antimicrobial Use in Aquaculture in a New ICARS-Supported Project in Vietnam

Last February, Dr Anders Dalsgaard, Dr Mabel de Leo, and Dr Mads Martinus visited Vietnam to initiate a project addressing the use of antimicrobials (AMU) in aquaculture farms. More specifically, this project aims to enhance the sustainable development of Pangasius and Tilapia aquaculture in Vietnam, focusing on reducing AMU through improved production systems and disease prevention strategies.

Read more

Enhancing Stewardship Efforts through Partnership Development in Kenya

In February 2024, Dr Jyoti Joshi and Dr Fabian Maza from the ICARS Science team travelled to Kenya in connection with the TANDEM-ABX project. Their focus was on scoping human health and strengthening stewardship efforts in the country. The visit aimed to foster collaboration, evaluate progress, and chart the course for future endeavours.

Read more

Advancing Sustainable Agriculture and AMR Solutions: Insights from Denmark’s Visit to Vietnam

On May 14, 2024, ICARS, in collaboration with the Danish embassy in Hanoi, Vietnam, organized a workshop focusing on antimicrobial resistance (AMR) mitigation. The event saw the participation of key stakeholders from the Ministry of Agriculture and Rural Development (MARD) and the Ministry of Health in Vietnam, along with local and regional representatives from various UN organizations, international organizations, embassies, and funders operating in the region.

Read more

A Year in Review 2023

In 2023, ICARS underwent significant organisational maturation, building upon the groundwork laid in preceding years. As our Executive Director took office, our expansion continued through collaborations with partners to implement and develop projects and activities, while also enhancing evidence generation to inform policy. We initiated new partnerships and strengthened existing ones nationally, regionally, and globally to advocate for country-owned AMR solutions, alongside efforts to reinforce capacity and capabilities in LMICs. Additionally, we successfully attracted new donors to support our mission and activities.

Read more